Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD)
Clinical trial NCT04857996 · COMPLETED
Trial details
- NCT number
- NCT04857996
- Sponsor
- Unity Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-25
- Primary completion
- 2023-04-06
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.